NeuroPace (NPCE) Income from Continuing Operations (2020 - 2026)
NeuroPace's quarterly Income from Continuing Operations came in at 6524000.0 in Q1 2026, little changed year-on-year from 6541089.06 in Q1 2025, and down 139.06% quarter-over-quarter from 2729000.0 in Q4 2025.
NeuroPace has reported Income from Continuing Operations for 7 years, with the latest figure at 6524000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations changed 0.26% year-over-year to 6524000.0; the trailing twelve-month figure through Mar 2026 stood at 20996000.0 (up 15.94% YoY), and the FY2025 full-year result was 20979000.0, up 23.56% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 6524000.0, down from 2729000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2729000.0 in Q4 2025, with the low at 12605000.0 in Q2 2022.
- Average Income from Continuing Operations over 5 years is 7902000.0, with a median of 7634000.0 recorded in 2024.
- Year-over-year, Income from Continuing Operations tumbled 101.12% in 2022 and soared 47.15% in 2025.
- Tracing NPCE's Income from Continuing Operations over 5 years: stood at 11000000.0 in 2022, then jumped by 41.23% to 6465000.0 in 2023, then grew by 20.12% to 5164000.0 in 2024, then soared by 47.15% to 2729000.0 in 2025, then plunged by 139.06% to 6524000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 6524000.0 (Q1 2026), 2729000.0 (Q4 2025), and 3578000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -6.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.52 Mn |
| Dec 31, 2025 | -2.73 Mn |
| Sep 30, 2025 | -3.58 Mn |
| Jun 30, 2025 | -8.17 Mn |
| Mar 31, 2025 | -6.51 Mn |
| Dec 31, 2024 | -5.16 Mn |
| Sep 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -7.63 Mn |
| Mar 31, 2024 | -8.98 Mn |
| Dec 31, 2023 | -6.47 Mn |
| Sep 30, 2023 | -7.37 Mn |
| Jun 30, 2023 | -9.25 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Sep 30, 2022 | -11.68 Mn |
| Jun 30, 2022 | -12.61 Mn |
| Mar 31, 2022 | -11.46 Mn |
| Dec 31, 2021 | -10.69 Mn |
| Sep 30, 2021 | -7.93 Mn |
| Jun 30, 2021 | -6.38 Mn |
| Mar 31, 2021 | -5.70 Mn |
| Dec 31, 2020 | -4.86 Mn |
| Sep 30, 2020 | -3.96 Mn |
| Jun 30, 2020 | -7.26 Mn |
| Mar 31, 2020 | -8.46 Mn |